Table 1.
Compound | Mechanism | Status |
---|---|---|
cAMP | Activates variety of ion channels and protein kinases | Cannot be used clinically for GBM [16] |
Rapamycin | Inhibits mTOR and induces autophagy | Clinical trial for GBM [81,82] |
Retigabine | Opens KCNQ2-5/Kv7.2–7.5 channels | Novel application for GBM |
Minoxidil | Opens K(ATP) channels | Novel application for GBM |
NS1643 | Opens hERG and potentiates KCNQ2-4 channels | Novel application for GBM |
Lamotrigine | Blocks voltage gated sodium channels | Novel application for GBM |
Pantoprazole | Proton pump inhibitor | Published for GBM [83] |
Temozolomide (TMZ) |
Alkylates/methylates DNA, induces autophagy, used in GBM treatment | Current standard treatment for GBM [84] |